{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:44:38Z","timestamp":1793835878655,"version":"4.6.1"},"reference-count":20,"publisher":"Cambridge University Press (CUP)","issue":"16","license":[{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"},{"start":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T00:00:00Z","timestamp":1534982400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>An evaluation of the relationship between predictors and immune response was conducted using data obtained from a clinical trial in 200 Czech healthy adults aged 24\u201365 years receiving a booster dose of a monovalent tetanus vaccine in 2017. The response was determined from ELISA antibody concentrations of paired sera obtained before and 4 weeks after the immunisation. While all subjects with initial antibody levels &lt;1.2 IU\/ml achieved a 100% seroconversion rate (at least a fourfold rise in antibodies), only 8% seroconversion was documented in subjects with initial levels &gt;2.2 IU\/ml. The immune response was not affected by sex, age, tetanus vaccine type, concomitant medication, related adverse events or post-vaccination period since there were no significant differences in geometric mean concentrations or seroconversion rates. The seroconversion rate of 56% in smokers was significantly lower than that of 73% achieved in non-smokers. Although the seroconversion rates did not differ between individuals with normal or higher body weight, the adjusted odds ratio (1.3; 95% Cl 1.08\u20131.60) revealed a positive correlation between seroconversion rate and body mass index (BMI). Although the vaccine-induced response was influenced by pre-vaccination antibody levels, smoking or BMI, the booster immunisation against tetanus produced a sufficient response regardless the predictors.<\/jats:p>","DOI":"10.1017\/s095026881800242x","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T11:21:23Z","timestamp":1535023283000},"page":"2079-2085","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":12,"title":["Predictors of the immune response to booster immunisation against tetanus in Czech healthy adults"],"prefix":"10.1017","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-1736","authenticated-orcid":false,"given":"M.","family":"Petr\u00e1\u0161","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ole\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2018,8,23]]},"reference":[{"key":"S095026881800242X_ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1985.03360220053027"},{"key":"S095026881800242X_ref12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.18869\/acadpub.johe.1.3.124","article-title":"Lower immunity to tetanus in cigarette smoker subjects","volume":"1","author":"Jafarzadeh","year":"2012","journal-title":"Journal of Occupational Health and Epidemiology"},{"key":"S095026881800242X_ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066092"},{"key":"S095026881800242X_ref3","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268817000516"},{"key":"S095026881800242X_ref1","unstructured":"WHO Expert Committee on Biological Standardization (2014) Sixty-third report. Recommendations to assure the quality, safety and efficacy of tetanus vaccines (adsorbed). WHO Technical Report Series No. 980. Available at http:\/\/www.who.int\/biologicals\/vaccines\/Tetanus_Recommendations_TRS_980_Annex_5.pdf (Accessed 10 December 2017)."},{"key":"S095026881800242X_ref14","doi-asserted-by":"publisher","DOI":"10.1080\/08916930600597326"},{"key":"S095026881800242X_ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2015.06.003"},{"key":"S095026881800242X_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.058"},{"key":"S095026881800242X_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00342-6"},{"key":"S095026881800242X_ref18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu245"},{"key":"S095026881800242X_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92796-X"},{"key":"S095026881800242X_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.03.071"},{"key":"S095026881800242X_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00236-3"},{"key":"S095026881800242X_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2011.208"},{"key":"S095026881800242X_ref5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1699-0463.1986.tb02093.x","article-title":"The fall-off in serum concentration of tetanus antitoxin after primary and booster vaccination","volume":"94","author":"Simonsen","year":"1986","journal-title":"Acta Pathologica Et Microbiologica Scandinavica"},{"key":"S095026881800242X_ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00446"},{"key":"S095026881800242X_ref11","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001311"},{"key":"S095026881800242X_ref17","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2014.55.1.126"},{"key":"S095026881800242X_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(87)90057-0"},{"key":"S095026881800242X_ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.11.104"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S095026881800242X","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T14:35:29Z","timestamp":1693838129000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S095026881800242X\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,23]]},"references-count":20,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S095026881800242X"],"URL":"https:\/\/doi.org\/10.1017\/s095026881800242x","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,23]]},"assertion":[{"value":"Copyright \u00a9 Cambridge University Press 2018\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}